Efficacy of mRNA anti-SARS-CoV-2 vaccination and dynamics of humoral immune response in patients with solid tumors: results from the institutional registry of an Italian tertiary cancer center

BACKGROUND: Systemic immunosuppression characterizing cancer patients represents a concern regarding the efficacy of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination, and real-world evidence is needed to define the efficacy and the dynamics of humoral immune response to...

Descripción completa

Detalles Bibliográficos
Autores principales: Fucà, Giovanni, Lecchi, Mara, Ciniselli, Chiara Maura, Ottini, Arianna, Spagnoletti, Andrea, Mazzeo, Laura, Morelli, Daniele, Frati, Paola, Stroscia, Martina, Ebrahem, Elisabella, Sottotetti, Elisa, Galli, Giulia, D’Elia, Maria Grazia, Lobefaro, Riccardo, Ducceschi, Monika, Di Guardo, Lorenza, Bhoori, Sherrie, Provenzano, Salvatore, Platania, Marco, Niger, Monica, Colombo, Elena, Nichetti, Federico, Duca, Matteo, Rivoltini, Licia, Mortarini, Roberta, Baili, Paolo, Apolone, Giovanni, de Braud, Filippo, Verderio, Paolo, Damian, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340426/
https://www.ncbi.nlm.nih.gov/pubmed/35923922
http://dx.doi.org/10.1177/17588359221108687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340426/
https://www.ncbi.nlm.nih.gov/pubmed/35923922
http://dx.doi.org/10.1177/17588359221108687

Ejemplares similares